1. Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors. Issue 11 (27th August 2022) Authors: Sharma, Shringi; Pepin, Xavier; Burri, Harini; Zheng, Lianqing; Kuptsova‐Clarkson, Nataliya; de Jong, Anouk; Yu, Ting; MacArthur, Holly L.; Majewski, Michal; Byrd, John C.; Furman, Richard R.; Ware, Joseph A.; Mann, James; Ramies, David; Munugalavadla, Veerendra; Sheridan, Louise; Tomkinson, Helen Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 11(2022) Page Start: 1294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗